AUS
NZ
UK
CA
USA
IND
Healt
Starpharma Makes Second Deal With AstraZeneca For Development Of Oncology Medicine
June 03, 2019 10:50 PM AEST| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) is a global lead which develops dendrimer products for pharmaceutical, life science and other applications. Located in Melbourne, its underlying technology revolves around dendrimers. SPL has two main developmen...
CLINUVEL PHARMACEUTICALS’s Drug SCENESSE® Goal Date Extended By The US FDA
June 03, 2019 10:46 PM AEST| By Team Kalkine MediaCLINUVEL PHARMACEUTICALS LTD (ASX: CUV) is a global biopharmaceutical player. It concentrates on developing and providing treatments for severe genetic and skin disorders. The company?s R&D has led to innovative treatments for patient groups, ran...
BARD1 Life Sciences’ European Patent No 2606358 Validated In France, Germany, Italy, Spain, Switzerland And UK
June 03, 2019 08:26 PM AEST| By Team Kalkine MediaA medical technology company, BARD1 Life Sciences Limited (ASX: BD1) is primarily involved in the research and development of non-invasive diagnostic tests for early detection of cancer. In an announcement dated 3rd June 2019, the company reported t...
Cann Group’s March 2019 Quarterly Highlights, Stock Trading Below a Major Support Line
June 03, 2019 03:03 PM AEST| By Team Kalkine MediaCann Group Limited (ASX: CAN) is amongst the several ASX listed healthcare companies, working in the medical cannabis space. The company has its own research and cultivation facilities and is aiming to provide access to medicinal cannabis for Austral...
A Glance At Three Healthcare Stocks – IMU, SUD, PTX
June 03, 2019 12:29 PM AEST| By Team Kalkine MediaAustralian healthcare companies are vigorously engaged in trying to address some of the biggest neglected medical needs in the world. Below are three such companies under investors? radar, with a robust product pipeline which are currently engaged in...
2 Healthcare Stocks On Opposite Side Of ASX Ladder - PCK And BIT
June 02, 2019 08:30 AM AEST| By Team Kalkine MediaPainChek Limited PainChek Limited (ASX: PCK) aims to provide innovative pain assessment products and services to people in pain. The focus is to improve the quality of life for the pain inflicted utilizing AI and face recognition technology. PCK?s t...
2 Health Care Stocks - FPH, COH
June 01, 2019 08:30 AM AEST| By Team Kalkine MediaFPH: Fisher & Paykel Healthcare Corporation Limited (ASX: FPH) is a market player which leads in dealing with design, production, and marketing of products and services to be used in respiratory and acute care, operation, and to cure sleep apnoe...
Mesoblast Announces Operational Highlights & Financial Results For Nine Months Ending March 31
May 31, 2019 11:45 PM AEST| By Team Kalkine MediaListed on the NASDAQ as MESO and ASX as MSB, Mesoblast Limited (ASX: MSB) is a world leader in developing allogeneic (off-the-shelf) cellular medicine. The company has facilities in Texas, New York, Melbourne and Singapore. On 31st May 2019, the com...
Telix Pharmaceuticals Joins Hands With Emory Winship Cancer Institute
May 31, 2019 10:00 PM AEST| By Team Kalkine MediaTelix Pharmaceuticals Limited (ASX: TLX) operates in the healthcare sector and is engaged in commercialisation and development of molecularly targeted radiation (MTR) products for the treatment of cancer. The company is based out of North Melbourne,...
Cynata Therapeutics Cymerus™ technology to be featured in ISCT presentations
May 31, 2019 03:05 PM AEST| By Team Kalkine MediaCynata Therapeutics Limited (ASX: CYP) is a clinical-stage stem cell and regenerative medicine company. Based in Australia, it aims to develop therapies based on Cymerus?. This is a proprietary therapeutic stem cell platform technology. The technolog...
Patrys Releases Pre-clinical Animal Data for Lead Candidate, PAT-DX1
May 31, 2019 12:55 PM AEST| By Team Kalkine MediaPatrys Limited (ASX: PAB), based in Melbourne, Australia, is a healthcare sector company focused on the development of therapeutic antibodies to treat a range of cancers and their subtypes. Some of its products in the pipeline and at different stages...
Mesoblast Limited Initiated The Rolling Submission Of BLA For GvHD
May 30, 2019 11:23 PM AEST| By Team Kalkine MediaCellular medicines developer, Mesoblast Limited (ASX: MSB) has achieved a major corporate milestone by filing the first component of a rolling submission for a Biologics License Application to U.S. Food and Drug Administration for its lead product ca...
3 Exciting Stocks in Health Care Space - PAR, NOX, RNO
May 30, 2019 11:20 PM AEST| By Team Kalkine MediaParadigm Biopharmaceuticals Limited: Paradigm Biopharmaceuticals Limited (ASX: PAR) is an Australian biopharmaceutical company. The company is into the R&D of therapeutic products for human use. It also focusses on repurposing pentosan polysulph...
A Glimpse At Biotech Company, Imugene Limited
May 30, 2019 05:34 PM AEST| By Team Kalkine MediaA biotechnology company with operations in America and Europe, Imugene Limited (ASX: IMU) deals with the development of cancer immunotherapies targeting B-cell peptide vaccines. The company?s product pipeline comprises of multiple immunotherapy B-cel...
ResApp Health Onboarded UK-Consultancy Firm; Two CE-marked Devices to be Finalised
May 30, 2019 01:06 PM AEST| By Team Kalkine MediaResApp Health Limited (ASX: RAP) is a leading digital health company. It focusses on making smartphone applications for the management and diagnosis of respiratory diseases. Its machine learning algorithms make use of sound to spot and calculate the...
A Glance At Medical Technology Company, LBT Innovations Limited
May 29, 2019 04:00 PM AEST| By Team Kalkine MediaLBT Innovations Limited (ASX: LBT) is a medical technology company based in Adelaide, South Australia and is engaged in the development of world?s leading products in microbiology automation. The company offers advanced technology solutions to the he...
Bionomics Announces Strategic Review Results; Shares Slipped On ASX
May 29, 2019 03:13 PM AEST| By Team Kalkine MediaBionomics Limited (ASX: BNO) is involved in the healthcare sector. It is a global, clinical stage biopharmaceutical company focused on developing better treatments for central nervous system disorders, including anxiety, depression and Alzheimer?s di...
A look at SUDA Pharmaceuticals’ Product Portfolio
May 29, 2019 03:04 PM AEST| By Team Kalkine MediaHeadquartered in Western Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a drug-delivery pharmaceutical company that develops low-risk, innovative pharmaceuticals to improve the health and lifestyle of patients, by utilising its OroMist? oro-mucosa...
Paradigm Announces Positive Results for iPPS; Stock Continues To Consolidate
May 29, 2019 02:48 PM AEST| By Team Kalkine MediaParadigm Biopharmaceuticals Limited (ASX: PAR) is a healthcare company which is focused on repurposing a FDA approved drug; injectable Pentosan Polysulfate Sodium (iPPS), having safe history of 60+ years for treating inflammation. Recently the compa...
Cellmid Updated on FY2020 Growth Strategy; Co-Subsidiary Appointed CEO
May 29, 2019 01:33 PM AEST| By Team Kalkine MediaCellmid Limited (ASX: CDY) is an Australian life sciences company from the Health Care sector, which develops products to treat cancer and chronic inflammatory diseases. On 28 May 2019, the company also provided an update on the FY2020 growth strate...
Advertise your brand on Kalkine Media